HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE
HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE
PLYMOUTH MEETING, Pa., March 26, 2024 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in a fireside chat at the upcoming 23rd Annual Needham Virtual Healthcare Conference on Monday, April 8, 2024, at 9:30 a.m. ET.
宾夕法尼亚州普利茅斯会议，2024年3月26日 /PRNewswire/ — Harmony Biosciences Holdings, Inc.（纳斯达克股票代码：HRMY）今天宣布，Harmony的管理团队将在即将到来的23日参加炉边谈话第三方 年度Needham虚拟医疗会议将于美国东部时间2024年4月8日星期一上午9点30分举行。
A webcast of the fireside chat will be available on the investor page of Harmony's website at
炉边谈话的网络直播将在Harmony网站的投资者页面上播出，网址为
About Harmony Biosciences
At Harmony Biosciences, we specialize in developing and delivering treatments for rare neurological diseases that others often overlook. We believe that where empathy and innovation meet, a better life can begin for people living with neurological diseases. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, PA, our team of experts from a wide variety of disciplines and experiences is driven by our shared conviction that innovative science translates into therapeutic possibilities for our patients, who are at the heart of everything we do. For more information, please visit .
关于和谐生物科学
在Harmony Biosciences，我们专门开发和提供其他人经常忽视的罕见神经系统疾病的治疗方法。我们相信，在同理心和创新相遇的地方，神经系统疾病患者可以开始更美好的生活。我们由Paragon Biosciences, LLC于2017年成立，总部位于宾夕法尼亚州普利茅斯会议。我们的专家团队由来自不同学科和经验的专家组成，我们的共同信念是，创新科学可以转化为患者的治疗可能性，而患者是我们所做一切的核心。欲了解更多信息，请访问。
Harmony Biosciences Investor Contact:
Luis Sanay, CFA
445-235-8386
[email protected]
和谐生物科学投资者联系方式：
路易斯·萨奈，特许金融分析师
445-235-8386
[电子邮件保护]
Harmony Biosciences Media Contact:
Cate McCanless
202-641-6086
[email protected]
和谐生物科学媒体联系人：
凯特·麦坎利斯
202-641-6086
[电子邮件保护]
SOURCE Harmony Biosciences
来源 Harmony Bios